Cargando…
Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632144/ https://www.ncbi.nlm.nih.gov/pubmed/21525438 http://dx.doi.org/10.2337/dc11-s202 |
_version_ | 1782266847680266240 |
---|---|
author | Hirshberg, Boaz Raz, Itamar |
author_facet | Hirshberg, Boaz Raz, Itamar |
author_sort | Hirshberg, Boaz |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3632144 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-36321442013-04-24 Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs Hirshberg, Boaz Raz, Itamar Diabetes Care Diabetes, Obesity and Hypertension Outcome Studies American Diabetes Association 2011-05 2011-04-22 /pmc/articles/PMC3632144/ /pubmed/21525438 http://dx.doi.org/10.2337/dc11-s202 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Diabetes, Obesity and Hypertension Outcome Studies Hirshberg, Boaz Raz, Itamar Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs |
title | Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs |
title_full | Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs |
title_fullStr | Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs |
title_full_unstemmed | Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs |
title_short | Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs |
title_sort | impact of the u.s. food and drug administration cardiovascular assessment requirements on the development of novel antidiabetes drugs |
topic | Diabetes, Obesity and Hypertension Outcome Studies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632144/ https://www.ncbi.nlm.nih.gov/pubmed/21525438 http://dx.doi.org/10.2337/dc11-s202 |
work_keys_str_mv | AT hirshbergboaz impactoftheusfoodanddrugadministrationcardiovascularassessmentrequirementsonthedevelopmentofnovelantidiabetesdrugs AT razitamar impactoftheusfoodanddrugadministrationcardiovascularassessmentrequirementsonthedevelopmentofnovelantidiabetesdrugs |